Mladen V. Tzvetkov

5.0k total citations
122 papers, 3.3k citations indexed

About

Mladen V. Tzvetkov is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mladen V. Tzvetkov has authored 122 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 33 papers in Molecular Biology and 25 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mladen V. Tzvetkov's work include Drug Transport and Resistance Mechanisms (38 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Pharmacogenetics and Drug Metabolism (17 papers). Mladen V. Tzvetkov is often cited by papers focused on Drug Transport and Resistance Mechanisms (38 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Pharmacogenetics and Drug Metabolism (17 papers). Mladen V. Tzvetkov collaborates with scholars based in Germany, United States and United Kingdom. Mladen V. Tzvetkov's co-authors include Jürgen Brockmöller, Ingolf Meineke, Julia Kirchheiner, Ivar Roots, Ali R. Saadatmand, Jörn Lötsch, Joao N.S. Pereira, David Sehrt, Stefan Viktor Vormfelde and Julia Stingl and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mladen V. Tzvetkov

117 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mladen V. Tzvetkov Germany 31 1.1k 823 781 740 472 122 3.3k
Xavier Declèves France 39 1.8k 1.6× 905 1.1× 1.1k 1.4× 510 0.7× 431 0.9× 149 4.5k
Tsuyoshi Fukuda United States 40 733 0.7× 951 1.2× 799 1.0× 1.1k 1.4× 764 1.6× 162 4.3k
Toshinori Yamamoto Japan 39 1.1k 0.9× 470 0.6× 1.3k 1.6× 824 1.1× 399 0.8× 183 4.2k
Shun Higuchi Japan 38 2.1k 1.9× 1.6k 2.0× 867 1.1× 1.2k 1.6× 532 1.1× 173 5.2k
Su Duan United States 26 761 0.7× 531 0.6× 534 0.7× 1.6k 2.1× 458 1.0× 43 2.9k
Shufeng Zhou China 34 913 0.8× 449 0.5× 2.3k 2.9× 1.2k 1.7× 819 1.7× 112 5.2k
Gary M. Pollack United States 42 2.3k 2.0× 1.7k 2.1× 958 1.2× 818 1.1× 469 1.0× 138 5.3k
Christoph Sachse Germany 22 861 0.8× 336 0.4× 1.1k 1.5× 1.4k 1.9× 438 0.9× 32 3.3k
Jean‐Michel Scherrmann France 42 2.0k 1.8× 934 1.1× 1.6k 2.1× 435 0.6× 360 0.8× 114 5.0k
Francisco Abad‐Santos Spain 31 466 0.4× 421 0.5× 527 0.7× 845 1.1× 390 0.8× 220 3.3k

Countries citing papers authored by Mladen V. Tzvetkov

Since Specialization
Citations

This map shows the geographic impact of Mladen V. Tzvetkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mladen V. Tzvetkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mladen V. Tzvetkov more than expected).

Fields of papers citing papers by Mladen V. Tzvetkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mladen V. Tzvetkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mladen V. Tzvetkov. The network helps show where Mladen V. Tzvetkov may publish in the future.

Co-authorship network of co-authors of Mladen V. Tzvetkov

This figure shows the co-authorship network connecting the top 25 collaborators of Mladen V. Tzvetkov. A scholar is included among the top collaborators of Mladen V. Tzvetkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mladen V. Tzvetkov. Mladen V. Tzvetkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neumann, Anna, et al.. (2025). Substrate-specific effects point to the important role of Y361 as part of the YER motif in closing the binding pocket of OCT1. Journal of Biological Chemistry. 301(4). 108318–108318.
2.
Hahnenkamp, Klaus, et al.. (2024). Individual use of self-medication and other remedies in COVID-19 outpatients in Western-Pomerania. Scientific Reports. 14(1). 21971–21971. 2 indexed citations
3.
Vollmer, Marcus, et al.. (2024). Sex‐Dependent Effects of CYP2D6 on the Pharmacokinetics of Berberine in Humans. Clinical Pharmacology & Therapeutics. 117(1). 250–260. 2 indexed citations
4.
Grimm, Michael, Mirko Koziolek, Marie‐Luise Kromrey, et al.. (2024). Prolongation of the gastric residence time of caffeine after administration in fed state: Comparison of effervescent granules with an extended release tablet. European Journal of Pharmaceutics and Biopharmaceutics. 199. 114313–114313.
5.
Schoon, Janosch, Axel Ekkernkamp, Johannes Reichert, et al.. (2023). Enhancing the Impact of Chemotherapy on Ewing Sarcoma Cells through Combination with Cold Physical Plasma. International Journal of Molecular Sciences. 24(10). 8669–8669. 4 indexed citations
6.
Blank, Antje, Gerd Mikus, David Czock, et al.. (2023). Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 49(1). 101–109. 2 indexed citations
7.
Grimm, Michael, et al.. (2023). Comparing the gastric emptying of 240 mL and 20 mL water by MRI and caffeine salivary tracer technique. European Journal of Pharmaceutics and Biopharmaceutics. 184. 150–158. 12 indexed citations
8.
9.
Wolf, Robert H., Raghavendra Palankar, Eileen Moritz, et al.. (2022). Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets. Haematologica. 107(9). 2206–2217. 9 indexed citations
10.
Moritz, Eileen, Gabriele Jedlitschky, Mladen V. Tzvetkov, et al.. (2021). Increased Sphingosine-1-Phosphate Serum Concentrations in Subjects with Periodontitis: A Matter of Inflammation. Journal of Inflammation Research. Volume 14. 2883–2896. 7 indexed citations
11.
Büttner, Benedikt, José Hinz, Ayelet Alpert, et al.. (2021). Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study. Journal of Clinical Medicine. 10(22). 5302–5302. 10 indexed citations
12.
Blank, Antje, et al.. (2020). Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial. Clinical Pharmacokinetics. 59(7). 927–939. 12 indexed citations
13.
Büttner, Benedikt, José Hinz, Ayelet Alpert, et al.. (2020). TIM-3 Genetic Variants Are Associated with Altered Clinical Outcome and Susceptibility to Gram-Positive Infections in Patients with Sepsis. International Journal of Molecular Sciences. 21(21). 8318–8318. 10 indexed citations
14.
Büttner, Benedikt, José Hinz, Aron‐Frederik Popov, et al.. (2019). Lack of an Association between the Functional Polymorphism TREM-1 rs2234237 and the Clinical Course of Sepsis among Critically Ill Caucasian Patients—A Monocentric Prospective Genetic Association Study. Journal of Clinical Medicine. 8(3). 301–301. 6 indexed citations
15.
Büttner, Benedikt, José Hinz, Ayelet Alpert, et al.. (2019). CTLA-4 Genetic Variants Predict Survival in Patients with Sepsis. Journal of Clinical Medicine. 8(1). 70–70. 17 indexed citations
16.
Jensen, Ole, et al.. (2019). Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans. Clinical Pharmacology & Therapeutics. 107(3). 628–638. 19 indexed citations
17.
Grimm, Michael, Mahmoud Hasan, Marie‐Luise Kromrey, et al.. (2019). In vivo characterization of enTRinsic™ drug delivery technology capsule after intake in fed state: A cross-validation approach using salivary tracer technique in comparison to MRI. Journal of Controlled Release. 313. 24–32. 15 indexed citations
18.
19.
Mansur, Ashham, Michael Ghadimi, Ingo Bergmann, et al.. (2015). The CD14 rs2569190 TT Genotype Is Associated with an Improved 30-Day Survival in Patients with Sepsis: A Prospective Observational Cohort Study. PLoS ONE. 10(5). e0127761–e0127761. 15 indexed citations
20.
Tzvetkov, Mladen V., Jürgen Brockmöller, Ivar Roots, & Julia Kirchheiner. (2008). Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment. Pharmacogenetics and Genomics. 18(6). 495–506. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Declèves Breakdown of academic impact, for papers by Tsuyoshi Fukuda Breakdown of academic impact, for papers by Toshinori Yamamoto Breakdown of academic impact, for papers by Shun Higuchi Breakdown of academic impact, for papers by Su Duan Breakdown of academic impact, for papers by Shufeng Zhou Breakdown of academic impact, for papers by Gary M. Pollack Breakdown of academic impact, for papers by Christoph Sachse Breakdown of academic impact, for papers by Jean‐Michel Scherrmann Breakdown of academic impact, for papers by Francisco Abad‐Santos
Rankless by CCL
2026